Fujishima, Motonobu Kawaguchi, Atsushi Maikusa, Norihide Kuwano, Ryozo Iwatsubo, Takeshi Matsuda, Hiroshi and Teipel, Stefan 2017. Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging. Journal of Alzheimer's Disease, Vol. 56, Issue. 1, p. 75.
Göthlin, Mattias Eckerström, Marie Rolstad, Sindre Wallin, Anders and Nordlund, Arto 2017. Prognostic Accuracy of Mild Cognitive Impairment Subtypes at Different Cut-Off Levels. Dementia and Geriatric Cognitive Disorders, Vol. 43, Issue. 5-6, p. 330.
Devlin, Kathryn N. and Giovannetti, Tania 2017. Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment. Neuropsychology Review, Vol. 27, Issue. 2, p. 101.
de Wit, Paul F. M. and Derix, Mayke M. A. 2017. Neuropsychologisch onderzoek bij de ziekte van Alzheimer: een casusbeschrijving. Neuropraxis, Vol. 21, Issue. 2, p. 34.
Gao, Hui Yan, Peipei Zhang, Shun Nie, Shuke Huang, Fenghong Han, Hao Deng, Qianchun Huang, Qingde Yang, Wei Wu, Hailei Yao, Ping Ye, Keqiang Xu, Jiqu and Liu, Liegang 2016. Chronic alpha-linolenic acid treatment alleviates age-associated neuropathology: Roles of PERK/eIF2α signaling pathway. Brain, Behavior, and Immunity, Vol. 57, p. 314.
Roor, Jeroen J. Dandachi-FitzGerald, Brechje and Ponds, Rudolf W. H. M. 2016. A case of misdiagnosis of mild cognitive impairment: The utility of symptom validity testing in an outpatient memory clinic. Applied Neuropsychology: Adult, Vol. 23, Issue. 3, p. 172.
Wang, Jingxin Cunningham, Robert Zetterberg, Henrik Asthana, Sanjay Carlsson, Cynthia Okonkwo, Ozioma and Li, Lingjun 2016. Label-free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals. PROTEOMICS - Clinical Applications, Vol. 10, Issue. 12, p. 1225.
Lemos, Raquel Cunha, Catarina Marôco, João Afonso, Ana Simões, Mário R and Santana, Isabel 2015. Free and Cued Selective Reminding Test is superior to the Wechsler Memory Scale in discriminating mild cognitive impairment from Alzheimer's disease. Geriatrics & Gerontology International, Vol. 15, Issue. 8, p. 961.
Frölich, L. 2014. „Mild neurocognitive disorder“ – eine Erkrankung? Kontra. Der Nervenarzt, Vol. 85, Issue. 5, p. 632.
Ghosh, Sayantani Libon, David and Lippa, Carol 2014. Mild Cognitive Impairment. American Journal of Alzheimer's Disease & Other Dementiasr, Vol. 29, Issue. 4, p. 293.
Damian, Marinella Hausner, Lucrezia Jekel, Katrin Richter, Melany Froelich, Lutz Almkvist, Ove Boada, Merce Bullock, Roger De Deyn, Peter Paul Frisoni, Giovanni B. Hampel, Harald Jones, Roy W. Kehoe, Patrick Lenoir, Hermine Minthon, Lennart Olde Rikkert, Marcel G.M. Rodriguez, Guido Scheltens, Philip Soininen, Hilkka Spiru, Luiza Touchon, Jacques Tsolaki, Magda Vellas, Bruno Verhey, Frans R.J. Winblad, Bengt Wahlund, Lars-Olof Wilcock, Gordon and Visser, Pieter Jelle 2013. Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study. Dementia and Geriatric Cognitive Disorders, Vol. 36, Issue. 1-2, p. 1.
Ritchie, Lesley J. and Tuokko, Holly 2010. Patterns of Cognitive Decline, Conversion Rates, and Predictive Validity for 3 Models of MCI. American Journal of Alzheimer's Disease & Other Dementiasr, Vol. 25, Issue. 7, p. 592.
Grossman, Iris Lutz, Michael W. Crenshaw, Donna G. Saunders, Ann M. Burns, Daniel K. and Roses, Allen D. 2010. Alzheimer’s disease: diagnostics, prognostics and the road to prevention. EPMA Journal, Vol. 1, Issue. 2, p. 293.
Lam, Linda C.W. Tam, Cindy W.C. Leung, Grace T.Y. Lui, Victor W.C. Fung, Ada W.T. Chiu, Helen F.K. Chan, Sandra S.M. Chan, Wai C. Ng, Sammy and Chan, Wai M. 2010. Combined Clinical and Cognitive Criteria to Identify Mild Cognitive Impairment in a Southern Chinese Community. Alzheimer Disease & Associated Disorders, Vol. 24, Issue. 4, p. 343.
Vestberg, Susanna Passant, Ulla and Elfgren, Christina 2010. Stability in the clinical characteristics of patients with memory complaints. Archives of Gerontology and Geriatrics, Vol. 50, Issue. 3, p. e26.
Mitchell, A. J. and Shiri-Feshki, M. 2009. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, Vol. 119, Issue. 4, p. 252.
Visser, P. J. 2009. Use of biomarkers to select the target population for clinical trials in subjects with mild cognitive impairment. The Journal of Nutrition, Health and Aging, Vol. 13, Issue. 4, p. 344.
Wang, Sheng-Chiang and Tzeng, Nian-Sheng 2008. Mild cognitive impairment presenting with delusional misidentification: A case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Issue. 8, p. 2008.
Miners, James Scott Baig, Shabnam Palmer, Jennifer Palmer, Laura E. Kehoe, Patrick G. and Love, Seth 2008. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ-Degrading Enzymes in Alzheimer's Disease. Brain Pathology, Vol. 18, Issue. 2, p. 240.
We investigated whether the predictive accuracy of mild cognitive impairment (MCI) for Alzheimer-type dementia (AD) in a clinical setting is dependent on age and the definition of MCI used.
Non-demented subjects older than 40 (n=320) who attended a memory clinic of a university hospital were reassessed 5 years later for the presence of AD. MCI was diagnosed according to the criteria of amnestic MCI, mild functional impairment (MFI), ageing-associated cognitive decline (AACD), and age-associated memory impairment (AAMI). The main outcome measure was the area under the curve (AUC) of a receiver operating characteristic (ROC) curve. Analyses were conducted on the entire sample and on subgroups of subjects aged 40–54, 55–69 and 70–85 years.
A diagnosis of AD at follow-up was made in 58 subjects. Four of them were in the 40–54 age group, 29 in the 55–69 age group and 25 in the 70–85 age group. The diagnostic accuracy in the entire sample was low to moderately high with AUCs ranging from 0.56 (AACD) to 0.75 (amnestic MCI). A good predictive accuracy with an AUC >0.80 was only observed in subjects aged 70–85 using the criteria of amnestic MCI (AUC=0.84).
The predictive accuracy of MCI for AD is dependent on age and the definition of MCI used. The predictive accuracy is good only for amnestic MCI in subjects 70–85 years. As subjects with prodromal AD are often younger than 70, the usefulness of MCI as predictor of AD in clinical practice is limited.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 19th November 2017. This data will be updated every 24 hours.